Paul de Bakker

Paul I. Wen de Bakker (born 1973) is a Dutch bioinformatician who specializes in computational biology and genetic epidemiology. He has been Senior Director of Computational Genomics at Vertex Pharmaceuticals since 2015. He previously worked at Harvard Medical School from 2007 to 2012, and served as Professor of Genetic Epidemiology and Bioinformatics at the University of Utrecht from 2012 to 2015.[3] He is known for his research on the genetics of innate resistance to HIV.[4][5][6]

Paul de Bakker
Born
Paul I. Wen de Bakker

24 August 1973 [1]
Rotterdam
NationalityNetherlands
EducationUniversity of Bristol
Utrecht University
University of Cambridge
Known forComputational genomics
Scientific career
FieldsComputational biology
Genetic epidemiology
InstitutionsHarvard Medical School (2007–2012)
University of Utrecht (2012–2015)
Vertex Pharmaceuticals (2015–present)
ThesisAb initio sampling of polypeptide conformations and the prediction of protein structure (2003)
Doctoral advisorTom Blundell[2]

References
  1. ProfessorProf.dr. P.I.W. de Bakker (1973 - ) at the Catalogus Professorum of the University of Utrecht
  2. "Paul de Bakker". Paul de Bakker Lab. Retrieved 2018-12-31.
  3. "News". McCammon Group. Retrieved 2018-12-31.
  4. Heisler, Gregory (2009-01-15). "The Rare Few". Proto Magazine. Retrieved 2018-12-31.
  5. Finkel, Elizabeth (2012). The Genome Generation. Melbourne Univ. Publishing. pp. 141–3. ISBN 9780522856477.
  6. Davis, Daniel Michael (2014). The Compatibility Gene: How Our Bodies Fight Disease, Attract Others, and Define Our Selves. Oxford University Press. p. 92. ISBN 9780199316410.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.